Session Details

S001 Hair Loss from Trichoscopy to Therapy

Fri, Mar 8, 9:00 AM - 12:00 PM
Room 6D
3 CME Available Symposium
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Trichoscopy became an important accessory method in the differential diagnosis of hair loss. It may influence therapeutic decisions. This session will provide an update on trichoscopy clues for the diagnosis of hair loss and the management of patients with common hair disorders, (e.g. androgenetic alopecia, alopecia areata, cicatricial alopecia). Diseases affecting the eyebrows and eyelashes will be discussed. Typical trichoscopy features of scalp metastases presenting with hair loss will be discussed.

LEARNING OBJECTIVES

1.

Diagnose hair loss more effectively

2.

Identify trichoscopy clues for the diagnosis of common hair diseases.

3.

Select best treatment for selected hair diseases

SCHEDULE

5:00 PM

Loss of eyebrows and eyelashes - from trichoscopy to therapy

Antonella Tosti, MD

5:15 PM

Alopecia areata - from trichoscopy to systemic therapy

Lidia Rudnicka, MD, PhD, IFAAD

5:30 PM

Androgenetic alopecia – from trichoscopy to treatment algorithms

Rodrigo Pirmez, MD

5:45 PM

Finasteride and dutasteride in androgenetic alopecia – efficacy and safety

Bianca Maria Piraccini, MD, IFAAD

6:00 PM

Q&A

6:15 PM

Dissecting cellulitis - from trichoscopy to therapy

DANIEL MELO, PhD

6:30 PM

Trichoscopy of tinea capitis in children and adults.

Daniel Asz-Sigall, MD, IFAAD

6:45 PM

How to not miss tumor metastases to the scalp?

Lidia Rudnicka, MD, PhD, IFAAD

7:00 PM

Q&A

7:15 PM

Central centrifugal cicatricial alopecia - from trichoscopy to therapy

Amy J McMichael, MD, FAAD

7:30 PM

Low dose oral minoxidil in hair diseases – evidence and experience

Jerry Shapiro, MD, FAAD

7:45 PM

Q&A

SPEAKERS

Daniel Asz-Sigall, MD, IFAAD

Daniel Asz-Sigall, MD, IFAAD

Amy J McMichael, MD, FAAD

Amy J McMichael, MD, FAAD

DANIEL MELO, PhD

DANIEL MELO, PhD

Bianca Maria Piraccini, MD, IFAAD

Bianca Maria Piraccini, MD, IFAAD

Rodrigo Pirmez, MD

Rodrigo Pirmez, MD

Lidia Rudnicka, MD, PhD, IFAAD

Lidia Rudnicka, MD, PhD, IFAAD

Jerry Shapiro, MD, FAAD

Jerry Shapiro, MD, FAAD

Antonella Tosti, MD

Antonella Tosti, MD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Daniel Asz-Sigall, MD, IFAAD

No financial relationships exist with ineligible companies.

Amy J McMichael, MD, FAAD

Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria), Investigator(Other Financial Benefit); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria);

DANIEL MELO, PhD

Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Biolab – Speaker(Fees); L'Oréal France – Consultant(Fees); Pfizer Inc. – Advisory Board(Fees); U.SK Under Skin – Speaker(Fees);

Bianca Maria Piraccini, MD, IFAAD

ISDIN – Consultant(Fees); L'Oréal France – Advisory Board(Fees); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);

Rodrigo Pirmez, MD

Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); Eli Lilly and Company – Consultant(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees); Vichy Laboratoires – Speaker(Fees);

Lidia Rudnicka, MD, PhD, IFAAD

La Roche-Posay Laboratoire Pharmaceutique – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Fees); Novartis – Speaker(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermo Cosmetique France – Speaker/Faculty Education(Other Financial Benefit); UCB – Speaker(Honoraria);

Jerry Shapiro, MD, FAAD

30 Madison – Consultant (1099 relationship)(Stock Options); Almirall – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria);

Antonella Tosti, MD

Almirall – Advisory Board(Fees); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); Thirty Madison, Inc. – Consultant(Honoraria);